The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

David L Paterson1

  • 1Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. patersond@dom.pitt.edu

Insights

Panresistant Pseudomonas aeruginosa and Acinetobacter strains are prevalent worldwide, often causing ventilator-associated pneumonia in intensive care units. Enhanced surveillance is crucial due to limited antibiotic treatment options for these highly resistant bacteria.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Prevalence of multidrug-resistant organisms, specifically Pseudomonas aeruginosa and Acinetobacter species, is a growing global concern.
  • These panresistant strains, resistant to nearly all antibiotics, are frequently isolated from intensive care unit (ICU) patients with ventilator-associated pneumonia (VAP).
  • Panresistance is defined by resistance to all beta-lactam and quinolone antibiotics recommended for empirical VAP treatment.

Purpose of the Study:

  • To highlight the increasing prevalence and clinical significance of panresistant Pseudomonas aeruginosa and Acinetobacter species.
  • To emphasize the association of these strains with ventilator-associated pneumonia in intensive care units.
  • To underscore the urgent need for enhanced surveillance strategies.

Main Methods:

  • Review of molecular epidemiological data on panresistant strain outbreaks.
  • Analysis of clinical recovery data from intensive care units.
  • Definition and characterization of panresistance in relation to empirical VAP therapy.

Main Results:

  • Panresistant Pseudomonas aeruginosa and Acinetobacter isolates are now globally prevalent.
  • These strains are predominantly found in intensive care units, often associated with ventilator-associated pneumonia.
  • Molecular epidemiology indicates successful adaptation and dissemination of specific clones within hospital environments.
  • Antibiotic use is identified as a potential selection pressure for panresistant strains.

Conclusions:

  • Panresistant strains pose a significant threat due to the lack of effective antibiotic treatment options.
  • Enhanced, multi-level surveillance (unit-specific, institutional, national) is essential for controlling the spread of these organisms.
  • Urgent strategies are needed to combat infections caused by panresistant bacteria in healthcare settings.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...